Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019

Using a test-negative design, the Canadian Sentinel Practitioner Surveillance Network assessed interim 2018/19 vaccine effectiveness (VE) against predominant influenza A(H1N1)pdm09 viruses. Adjusted VE was 72% (95% confidence interval: 60 to 81) against medically attended, laboratory-confirmed influ...

Descripción completa

Detalles Bibliográficos
Autores principales: Skowronski, Danuta M, Leir, Siobhan, Sabaiduc, Suzana, Murti, Michelle, Dickinson, James A, Olsha, Romy, Gubbay, Jonathan B, Croxen, Matthew A, Charest, Hugues, Chan, Tracy, Bastien, Nathalie, Li, Yan, Krajden, Mel, De Serres, Gaston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2019
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351998/
https://www.ncbi.nlm.nih.gov/pubmed/30696523
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.4.1900055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351998/
https://www.ncbi.nlm.nih.gov/pubmed/30696523
http://dx.doi.org/10.2807/1560-7917.ES.2019.24.4.1900055

Ejemplares similares